European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Healthcare Providers by Country

The 2023 European healthcare expenditure on pharmaceuticals and medical non-durable goods shows significant variation among countries. Bulgaria leads at 29.06%, experiencing a slight decline. Greece, at 28.07%, and Bosnia and Herzegovina, at 24.25%, have seen marginal increases. Conversely, countries like Slovakia and Romania are projected to face notable decreases. Low expenditure levels are evident in Nordic countries such as Denmark, at 6.2%, and the Netherlands, at 6.38%. Recent trends point to Malta's substantial growth and Latvia's significant downturn.

Future trends to watch include the potential impact of digital health innovations, policy changes, and economic factors influencing pharmaceutical expenditure. Increasing emphasis on value-based care and personalized medicine is likely to reshape expenditure patterns across Europe.